|
EGFR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.620000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.259590E-01 |
| Normal-vs-Stage2 |
9.805800E-01 |
| Normal-vs-Stage3 |
3.097200E-01 |
| Normal-vs-Stage4 |
7.466800E-01 |
| Stage1-vs-Stage2 |
3.746600E-01 |
| Stage1-vs-Stage3 |
9.139200E-03 |
| Stage1-vs-Stage4 |
1.099790E-01 |
| Stage2-vs-Stage3 |
4.987600E-01 |
| Stage2-vs-Stage4 |
8.014000E-01 |
| Stage3-vs-Stage4 |
6.016000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.091600E-01 |
| Normal-vs-AfricanAmerican |
3.883400E-01 |
| Normal-vs-Asian |
5.783400E-01 |
| Caucasian-vs-AfricanAmerican |
5.822000E-01 |
| Caucasian-vs-Asian |
9.998200E-01 |
| AfricanAmerican-vs-Asian |
6.725200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.566200E-01 |
| Normal-vs-Female |
2.300600E-01 |
| Male-vs-Female |
6.865500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.343010E-01 |
| Normal-vs-Age(41-60Yrs) |
6.821600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.745800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.300400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.492800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.447600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.680470E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.210600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.878500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.503800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.276720E-03 |
| Classical-VS-Follicular |
7.84800002762154E-09 |
| Classical-VS-Other |
1.590560E-01 |
| Classical-VS-Normal |
1.354400E-02 |
| Tall-VS-Follicular |
6.728200E-02 |
| Tall-VS-Other |
4.821400E-01 |
| Tall-VS-Normal |
3.078400E-01 |
| Follicular-VS-Other |
7.899600E-01 |
| Follicular-VS-Normal |
2.075800E-03 |
| Other-VS-Normal |
2.018400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.948600E-01 |
| Normal-vs-N1 |
7.278800E-01 |
| N0-vs-N1 |
7.393400E-01 |
|
|
